Navigation Links
Polypill for Heart Ailments Being Tested in India

The Dr Reddy's Laboratories (DRL), a leading Indian pharmaceutical firm, says it is conducting the first-ever clinical trials for an all-in-one polypill// for heart problems on 250 patients in the country. According to Raghu Cidambi of DRL, "We hope to put it in the market by the end of this year."

The proposed polypill will contain drugs for dilating arteries, relaxing heart muscles, removing excess water and salts, preventing clot formation, and reducing "bad" cholesterol.

The subjects of the trial have all already suffered a cardiac event. The trial is for establishing whether the polypill can prevent recurrence of cardiac problems.

Though a polypill was first suggested by two British scientists in 2003, this is the first time such a drug is being tested anywhere in the world on human subjects.

If the trials succeed, the polypill may have a worldwide market. Every year, over 17.5 million persons die due to heart diseases all over the world. India has the dubious distinction of having the largest share - over 1.5 million.

By 2010, India is projected to have 60% of the world's heart patients fuelled by risky lifestyles — which include junk food, lack of exercise and smoking — and the increasing number of elderly people.

The DRL is hoping to open up yet another vista. Even those who have not suffered an attack or a stroke could take the polypill if they think that they are liable to fall victim to cardio-vascular diseases.

Clinical trials to establish that aspect of the drug would start after necessary permission is granted by the Drug Controller of India.

However experts say such one-size-fits-all approach may not work. They note that dosage may vary from person to person.

Besides it could make people complacent about risk factors like smoking, diet, stress and exercise, they caution.
SR
'"/>




Page: 1

Related medicine news :

1. “Polypill”- to prevent recurrent heart diseass
2. Dr. Reddys To Launch Polypill For Treating Heart Disease
3. One in Three Heart Attack Patients Have No Chest Pains
4. Epileptic Seizures Can Be Due to Heart Problem
5. Bypass Heart Surgery Performed Without General Anesthesia
6. New CPR Guidelines issued by Heart Association
7. White Cells Count Can Predict Heart Attack Death Risk
8. Vitamins-The answer to Heart Disease?
9. Fight Heart disease and Pain with Meditation
10. Heart disease in the newborn is related to maternal malnutrition
11. New drug to treat Heart Attack and damaged tissue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... 18, 2017 , ... Moore Insurance, a Houston area agency ... is launching a regional charity effort to provide publicity assistance and generate donations ... Tumor Foundation (PBTF) has raised nearly $30 million in donations that has been ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, has become a ... conditions of aging, such as menopause, andropause, thyroid disorder and adrenal insufficiencies. ...
(Date:8/18/2017)... ... 18, 2017 , ... Inc. magazine has ranked American Specialty Health, Incorporated (ASH) ... nation's fastest-growing private companies. This marks the eighth time in the last nine years ... year’s ranking reflects ASH’s 76 percent overall revenue growth from 2013 ($239 million) through ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the ... Diane is from Southwest Nebraska where she was raised on a farm. As ... story is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 million ... continuing operations Second-quarter 2017 ... million Second-quarter 2017 Sterile ... Second-quarter 2017 adjusted diluted earnings ... to $0.93 Second-quarter 2017 ...
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc ... reached agreements to resolve virtually all known U.S. mesh ... discussions to resolve the known remaining U.S. claims at ... payments beginning in the fourth quarter of 2017 and ... of its second quarter 2017 results, the Company intends ...
(Date:8/2/2017)... , Aug. 2, 2017   Marshall County Hospital in Benton, Kentucky ... reduce the risk of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short ... to kill deadly pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
Breaking Medicine Technology: